TTP have been an invaluable long-term partner for AstraZeneca. They have both the deep expertise and creativity to generate innovative concepts, and the horsepower to rapidly accelerate these through design verification.
Drug Delivery Systems
We can help you address the challenges in your drug delivery systems project and drive forward the development of next-generation devices and solutions for on-body and off-body treatments.
We develop next-generation drug delivery systems for our clients.
Pharmaceutical companies face substantial challenges, from constraints in health spending to weakening drug pipelines. Yet opportunities exist for those bold enough to adapt, ranging from connected devices that drive adherence to generic devices at cost points previously thought impossible.
TTP is working with clients at all stages of the product development life cycle. From helping companies to explore and define new business opportunities, through to using a first principles approach to troubleshoot late stage problems in scale-up and commercialisation. But in all cases using highly skilled, multidisciplinary teams to develop market leading drug delivery systems, products and services routinely.
Drug Delivery Systems – Why TTP
Large Volume Delivery
We specialise in the delivery of large-volume formulations and understand the constraints, and trade-offs, of large-volume, high-viscosity injectors and devices in order to rapidly bring solutions to market.
Connected Digital Health Ecosystem
We leverage our expertise in human factors, biomechanics, and engineering to deliver connected drug delivery injectors, inhalers, and other devices that can fit into large and complex digital health ecosystems and patient workflows.
Adherence Modelling for Sustainable Innovation
We understand the value of adherence models to drive sustainable innovation. At TTP, we use complex behavioural science to underpin our adherence model in order to create better interventions, design future disease management solutions, predictive models, and valuable decision-making tools.
TTP’s adherence modelling provides clients with holistic thinking and insight into their connected device developments for sustainable innovation.